Albion News

G Network
G.Network, Albion Capital and Cube IM are pleased to announce that G.Network and Albion have closed an agreement with Cube Infrastructure Fund II, whereby Cube II is providing an initial GBP60 million of additional funding to G.Network. G.Network is a fast-growing full fibre local access connectivity provider focused on London. G.Network is building and operating new Fibre to the Premises (FTTP) infrastructure across the capital to provide affordable ultra-fast fibre connectivity to businesses and residents. G.Network’s full fibre local access solutions are bridging the gap between old... read more
Dysis Imaging
DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra Colposcope used in cervical cancer screening, announced today the appointment of Darin Hammers as Chief Executive Officer and a member of the board of directors. In addition, Michael Gioffredi was appointed as Chief Commercial Officer. Former CEO Alastair Atkinson will remain with the company and assume the role of Chief Operating Officer. “We believe that Mr. Hammers and Mr. Gioffredi have the right leadership experience and knowledge of the U.S. medical device market to establish DYSIS as the leader in Colposcopy. On behalf of... read more
Hazy AI
Hazy -  has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch. Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCLTechnology Fund which is managed by Albion in collaboration with UCLB. Hazy is a platform that helps businesses identify and anonymise personal data in large datasets whilst maintaining its utility, enabling Hazy’s customers to remain GDPR compliant. Hazy uses ML techniques to capture trends, patterns, and correlations in data in a single, compressed model, and then use this model to generate synthetic data that... read more
MeiraGTx
UCL Technology Fund investment MeiraGTx Holdings plc (‘MeiraGTx’), the clinical stage gene therapy company, has raised $75million at IPO, pricing five million shares at $15.00 per share on the Nasdaq Global Select Market on June 12 2018. The UCL Technology Fund (UCLTF) is managed by Albion Capital in collaboration with UCL Business (UCLB), UCL’s commercialisation company, and is dedicated to bringing UCL’s world-class research in life and physical sciences to commercial reality. MeiraGTx is its first investment to IPO. MeiraGTx has strong roots in UCL; its rare eye diseases business was borne... read more
uMotif
uMotif, the data capture company putting patients at the centre of clinical research, has raised £2.4 million in its latest funding round led by Albion Capital, the leading independent investment manager, along with several angel investors. uMotif’s software platform provides the patient-facing technology required to capture real-world data (eCOA, ePRo, eConsent) for the next generation of clinical research initiatives – from early phase to post-marketing trials. The technology is already in use by top pharma companies across Europe and North America, including AstraZeneca, Novartis and UCB... read more
Bloomsbury AI
The UCL Technology Fund is very proud to have backed BloomsburyAI and we are delighted that they are joining Facebook team in London.   For the full story please visit https://lnkd.in/eiX6Zsy read more
Dysis
DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra colposcope used in cervical cancer screening, announces today the completion of an £18 million ($25 million) investment. For the full story please click here read more
Oxsensis
Modern aviation owes much of its success to gas turbine engines that convert fuel into massive thrust, enabling large passenger aircraft to travel long distances at high speeds. Jet engines, however, require large fuel loads, most of which is carried in fuel tanks that span both of an aircraft’s main wings. The Airbus A380, for example, has a maximum fuel capacity of over 85,000 gallons. To ensure the safety of flight, the commanding pilot is required to accurately monitor and log fuel consumption rates to properly manage the plane’s weight and balance.  Understanding the critical importance... read more
Panaseer
Cyber security software company Panaseer has secured USD10 million in a Series A funding round led by Evolution Equity Partners with participation from existing investors including Notion Capital, Albion Capital, Winton Ventures and Paladin Capital Group, as well as new investor Cisco Investments. The Panaseer platform uses proprietary algorithms to perform ‘entity resolution’ to create an accurate view of an organisation’s assets, such as devices, applications and people. The platform continuously measures the security of these assets by automatically analysing data from the myriad of... read more
Healios
Healios, the digital therapy company for mental health, has raised £2.2m ($3m) in its latest funding round, led by investors Albion Capital and Spice Capital. Founded in 2013, Healios empowers young patients and families affected by mental illness and neurodevelopmental conditions through combining the use of technology with specialised clinician expertise and evidence-based clinical tools. Utilising its unique digital platform, Healios enables the efficient delivery of family-centric care, delivering a revolutionary interactive experience across multiple family members. Its technology-driven... read more

Pages